A carregar...
Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics
Although the CD20-targeted monoclonal antibody rituximab (RTX) has revolutionized the therapeutic landscape for B-cell malignancy, relapsed and refractory disease due to RTX resistance continue to constitute major challenges, illustrating the need for better therapies. Here, we apply drug-free macro...
Na minha lista:
| Publicado no: | ACS Nano |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5916500/ https://ncbi.nlm.nih.gov/pubmed/29595951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsnano.8b00797 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|